135 related articles for article (PubMed ID: 26953670)
1. Heparin-Based Polyelectrolyte Complex Enhances the Therapeutic Efficacy of Bone Morphogenetic Protein-2 for Posterolateral Fusion in a Large Animal Model.
Wang M; Lam RWM; Abbah SA; Hu T; Toh SY; Cool S; Bhakoo K; Li J; Goh JCH; Wong HK
Spine (Phila Pa 1976); 2016 Aug; 41(15):1199-1207. PubMed ID: 26953670
[TBL] [Abstract][Full Text] [Related]
2. Polyelectrolyte Complex Carrier Enhances Therapeutic Efficiency and Safety Profile of Bone Morphogenetic Protein-2 in Porcine Lumbar Interbody Fusion Model.
Wang M; Abbah SA; Hu T; Lam RW; Toh SY; Liu T; Cool SM; Bhakoo K; Li J; Goh JC; Wong HK
Spine (Phila Pa 1976); 2015 Jul; 40(13):964-73. PubMed ID: 25893351
[TBL] [Abstract][Full Text] [Related]
3. Novel Protamine-Based Polyelectrolyte Carrier Enhances Low-Dose rhBMP-2 in Posterolateral Spinal Fusion.
Hu T; Abbah SA; Wang M; Toh SY; Lam RW; Naidu M; Bhakta G; Cool SM; Bhakoo K; Li J; Goh JC; Wong HK
Spine (Phila Pa 1976); 2015 May; 40(9):613-21. PubMed ID: 25705961
[TBL] [Abstract][Full Text] [Related]
4. Minimizing the severity of rhBMP-2-induced inflammation and heterotopic ossification with a polyelectrolyte carrier incorporating heparin on microbead templates.
Wang M; Abbah SA; Hu T; Toh SY; Lam RW; Goh JC; Wong HK
Spine (Phila Pa 1976); 2013 Aug; 38(17):1452-8. PubMed ID: 23380826
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow mesenchymal stem cells with low dose bone morphogenetic protein 2 enhances scaffold-based spinal fusion in a porcine model.
Hu T; Liu L; Lam RWM; Toh SY; Abbah SA; Wang M; Ramruttun AK; Bhakoo K; Cool S; Li J; Cho-Hong Goh J; Wong HK
J Tissue Eng Regen Med; 2022 Jan; 16(1):63-75. PubMed ID: 34687157
[TBL] [Abstract][Full Text] [Related]
6. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates.
Barnes B; Boden SD; Louis-Ugbo J; Tomak PR; Park JS; Park MS; Minamide A
Spine (Phila Pa 1976); 2005 May; 30(10):1127-33. PubMed ID: 15897825
[TBL] [Abstract][Full Text] [Related]
7. Bone Regeneration by Controlled Release of Bone Morphogenetic Protein-2: A Rabbit Spinal Fusion Chamber Molecular Study.
Hu T; Naidu M; Yang Z; Lam WM; Kumarsing RA; Ren X; Ng F; Wang M; Liu L; Tan KC; Kwok KT; Goodman SB; Goh JC; Wong HK
Tissue Eng Part A; 2019 Oct; 25(19-20):1356-1368. PubMed ID: 30727849
[TBL] [Abstract][Full Text] [Related]
8. Synergistic Effect of NELL-1 and an Ultra-Low Dose of BMP-2 on Spinal Fusion.
Liu L; Lam WMR; Naidu M; Yang Z; Wang M; Ren X; Hu T; Kumarsing R; Ting K; Goh JC; Wong HK
Tissue Eng Part A; 2019 Dec; 25(23-24):1677-1689. PubMed ID: 31337284
[TBL] [Abstract][Full Text] [Related]
9. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
[TBL] [Abstract][Full Text] [Related]
10. Early-term and mid-term histologic events during single-level posterolateral intertransverse process fusion with rhBMP-2/collagen carrier and a ceramic bulking agent in a nonhuman primate model: implications for bone graft preparation.
Khan SN; Toth JM; Gupta K; Glassman SD; Gupta MC
J Spinal Disord Tech; 2014 Jun; 27(4):212-9. PubMed ID: 23073151
[TBL] [Abstract][Full Text] [Related]
11. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model.
Miyazaki M; Zuk PA; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Wang JC
Spine (Phila Pa 1976); 2008 Apr; 33(8):863-9. PubMed ID: 18404105
[TBL] [Abstract][Full Text] [Related]
12. Is lumbar facet fusion biomechanically equivalent to lumbar posterolateral onlay fusion?
Toth JM; Foley KT; Wang M; Seim HB; Simon Turner A
J Neurosurg Spine; 2017 May; 26(5):586-593. PubMed ID: 28156207
[TBL] [Abstract][Full Text] [Related]
13. The bone morphogenetic protein-2/7 heterodimer is a stronger inducer of bone regeneration than the individual homodimers in a rat spinal fusion model.
Morimoto T; Kaito T; Matsuo Y; Sugiura T; Kashii M; Makino T; Iwasaki M; Yoshikawa H
Spine J; 2015 Jun; 15(6):1379-90. PubMed ID: 25733023
[TBL] [Abstract][Full Text] [Related]
14. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
[TBL] [Abstract][Full Text] [Related]
15. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
16. The Effects of High-Dose Parathyroid Hormone Treatment on Fusion Outcomes in a Rabbit Model of Posterolateral Lumbar Spinal Fusion Alone and in Combination with Bone Morphogenetic Protein 2 Treatment.
Holmes CA; Ishida W; Elder BD; Lo SL; Chen YA; Kim E; Locke J; Taylor M; Witham TF
World Neurosurg; 2018 Jul; 115():e366-e374. PubMed ID: 29678698
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion.
Kraiwattanapong C; Boden SD; Louis-Ugbo J; Attallah E; Barnes B; Hutton WC
Spine (Phila Pa 1976); 2005 May; 30(9):1001-7; discussion 1007. PubMed ID: 15864149
[TBL] [Abstract][Full Text] [Related]
18. Binding to COMP Reduces the BMP2 Dose for Spinal Fusion in a Rat Model.
Refaat M; Klineberg EO; Fong MC; Garcia TC; Leach JK; Haudenschild DR
Spine (Phila Pa 1976); 2016 Jul; 41(14):E829-E836. PubMed ID: 26679888
[TBL] [Abstract][Full Text] [Related]
19. Heterotopic ossification following single-level anterior cervical discectomy and fusion: results from the prospective, multicenter, historically controlled trial comparing allograft to an optimized dose of rhBMP-2.
Arnold PM; Anderson KK; Selim A; Dryer RF; Kenneth Burkus J
J Neurosurg Spine; 2016 Sep; 25(3):292-302. PubMed ID: 27129045
[TBL] [Abstract][Full Text] [Related]
20. Controlled delivery of low-dose bone morphogenetic protein-2 using heparin-conjugated fibrin in the posterolateral lumbar fusion of rabbits.
Koo KH; Lee JM; Ahn JM; Kim BS; La WG; Kim CS; Im GI
Artif Organs; 2013 May; 37(5):487-94. PubMed ID: 23461810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
